Regenerative lineages and immune-mediated pruning in lung cancer metastasis

Ashley M Laughney1,2,3,4,5, Jing Hu1, Nathaniel R Campbell1,2,6

  • 1Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Nature Medicine
|February 12, 2020
PubMed

Insights

Cancer cells hijack normal lung regeneration pathways. Primary tumors show regenerative cells, while metastases exhibit primitive stem-like programs, conferring immune resistance and driving tumor spread.

Area of Science:

  • Cancer Biology
  • Developmental Biology
  • Immunology

Background:

  • Normal tissue regeneration processes are linked to cancer development.
  • The role of these processes during tumor progression and immune surveillance is not fully understood.

Purpose of the Study:

  • To investigate the enactment of regenerative processes in human lung adenocarcinomas.
  • To understand the role of developmental transcription factors in tumor progression and metastasis.
  • To explore the interplay between developmental plasticity and immune surveillance in metastasis.

Main Methods:

  • Analysis of human primary lung adenocarcinomas.
  • Characterization of transcription factor profiles in primary tumors and metastases.
  • Utilized a mouse model for spontaneous metastatic outbreak from dormancy.
  • Investigated natural killer cell resistance mechanisms.

Main Results:

  • Primary lung adenocarcinomas exhibit regenerative cell types and aberrant transcription factor expression.
  • Metastases are enriched in SOX2 and SOX9 transcription factors, recapitulating primitive progenitor states.
  • SOX9 confers resistance to natural killer cells, and its loss of constraint in macrometastases is linked to immune cell depletion.

Conclusions:

  • Tumor progression involves the re-emergence of developmental and regenerative programs.
  • Specific transcription factors (SOX2, SOX9) are crucial for metastatic potential and immune evasion.
  • A dynamic interplay exists between developmental plasticity and immune-mediated selection during metastasis.

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K